Thomas Malley, Director at Puma Biotechnology, holds 81.34K shares in Kiniksa Pharmaceuticals (Ticker: KNSA), holds 139.56K shares in Kura Oncology (Ticker: KURA), holds 76.70K shares in BeiGene (Ticker: BGNE).
What is the percentage of profitable transactions made by Thomas Malley?
The percentage of profitable transactions made by Thomas Malley is 50%.
What is the average return per transaction made by Thomas Malley?
The average return per transaction made by Thomas Malley is 31.00%.
What stocks does Thomas Malley hold?
Thomas Malley holds: PBYI, BGNE, KURA, KNSA, TPST, GEVA stocks.
What was Thomas Malley’s latest transaction?
Thomas Malley latest transaction was an Uninformative Buy of $85.36K.
What was Thomas Malley's most profitable transaction?
Thomas Malley’s most profitable transaction was an Informative Buy of BGNE stock on November 28, 2016. The return on the trade was 182.00%.
What is Thomas Malley's role in Puma Biotechnology?
Thomas Malley's role in Puma Biotechnology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.